ES2029853T5 - Base de unguento y unguento. - Google Patents

Base de unguento y unguento.

Info

Publication number
ES2029853T5
ES2029853T5 ES88100205T ES88100205T ES2029853T5 ES 2029853 T5 ES2029853 T5 ES 2029853T5 ES 88100205 T ES88100205 T ES 88100205T ES 88100205 T ES88100205 T ES 88100205T ES 2029853 T5 ES2029853 T5 ES 2029853T5
Authority
ES
Spain
Prior art keywords
ointment
gel ointment
base
resistant
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88100205T
Other languages
English (en)
Other versions
ES2029853T3 (es
Inventor
Takuzo Kamishita
Takashi Miyazaki
Yoshihide Okuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toko Yakuhin Kogyo KK
Original Assignee
Toko Yakuhin Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11655051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2029853(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toko Yakuhin Kogyo KK filed Critical Toko Yakuhin Kogyo KK
Application granted granted Critical
Publication of ES2029853T3 publication Critical patent/ES2029853T3/es
Publication of ES2029853T5 publication Critical patent/ES2029853T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA BASE DE UNGUENTO GEL, QUE TIENE VISCOSIDAD ESTABLE Y RESISTENTE A LA LUZ, QUE COMPRENDE UNA DISOLUCION ACUOSA DE POLIMERO DE CARBOXIVINILO Y UN AMINOACIDO, EN CANTIDAD EFICAZ PARA AUMENTAR LA VISCOSIDAD DE LA DISOLUCION ACUOSA DE POLIMERO DE CARBOXIVINILO, Y UN UNGUENTO GEL, CONTIENE UNA SUSTANCIAL MEDICINAL ACTIVA Y LA BASE DE UNGUENTO GEL COMO SE EXPLICO ANTES, QUE TIENE VISCOSIDAD ESTABLE Y RESISTENTE A LA LUZ, EN UN INTERVALO DE PH QUE NO PRODUCE NINGUNA IRRITACION A LAS MEMBRANAS VISCOSAS Y A LA PIEL
ES88100205T 1987-01-14 1988-01-09 Base de unguento y unguento. Expired - Lifetime ES2029853T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62007044A JPS63174924A (ja) 1987-01-14 1987-01-14 軟膏基剤および軟膏剤

Publications (2)

Publication Number Publication Date
ES2029853T3 ES2029853T3 (es) 1992-10-01
ES2029853T5 true ES2029853T5 (es) 2000-07-01

Family

ID=11655051

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88100205T Expired - Lifetime ES2029853T5 (es) 1987-01-14 1988-01-09 Base de unguento y unguento.

Country Status (8)

Country Link
US (1) US4983386A (es)
EP (1) EP0275054B2 (es)
JP (1) JPS63174924A (es)
AT (1) ATE66140T1 (es)
AU (1) AU607959B2 (es)
CA (1) CA1324078C (es)
DE (1) DE3864149D1 (es)
ES (1) ES2029853T5 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
WO1990013284A1 (en) * 1989-04-29 1990-11-15 Fisons Plc Pharmaceutical composition containing sodium cromoglycate
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
WO1994025058A1 (en) * 1993-04-30 1994-11-10 Center For Innovative Technology Topical compositions for re-epitheliazation of persistent epithelial defects
US5595753A (en) * 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract
CA2220927C (en) * 1996-03-15 2008-04-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Tissue adhesive suitable for spray application
US8048875B1 (en) 1997-02-24 2011-11-01 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
CN1127333C (zh) * 1997-02-24 2003-11-12 S.L.A.药业股份公司 含有胆碱能药物或钙通道阻滞剂的局部用医药组合物
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
JP4577996B2 (ja) * 2001-01-18 2010-11-10 株式会社ノエビア 皮膚化粧料
US7179476B2 (en) * 2001-08-09 2007-02-20 Sekisui Chemical Co., Ltd. Medical composition for external use for dermatosis
US7714011B2 (en) 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
ATE432484T1 (de) * 2003-04-03 2009-06-15 Seed Co Ltd Kontaktlinsen mit der fähigkeit einer andauernden medikamentenfreigabe und schutzlösungen dafür
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
WO2007013591A1 (ja) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. ゲル状組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
WO2008088922A2 (en) * 2007-01-19 2008-07-24 Genentech, Inc. Prevention of hydrogel viscosity loss
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
WO2019134159A1 (zh) * 2018-01-08 2019-07-11 刘琦 一种白头翁皂苷b4的直肠粘膜给药制剂及其制备方法
KR102219317B1 (ko) * 2020-10-06 2021-02-24 엘앤피코스메틱 (주) 천연 보습인자를 이용하여 형성된 미셀 복합체를 포함하는 화장료 조성물의 제조방법 및 이로부터 제조된 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
AU8409582A (en) * 1981-06-15 1982-12-23 Alcon Laboratories, Inc. Urea and carboxyvinyl polymers gel compositions
JPS5920217A (ja) * 1982-07-27 1984-02-01 Kawaken Fine Chem Co Ltd 尿素を安定に含む水性ゼリ−状組成物
JPS5948413A (ja) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd クリダナクを含有する消炎鎮痛外用剤
EP0162007A1 (de) * 1984-04-18 1985-11-21 Geriaco AG Stabiles, lagerungsfähiges Insulinpräparat zur Behandlung von Akne vulgaris
JPH0745393B2 (ja) * 1986-01-08 1995-05-17 サンスタ−株式会社 弱酸性ゲル状化粧料

Also Published As

Publication number Publication date
AU1022588A (en) 1988-07-21
US4983386A (en) 1991-01-08
CA1324078C (en) 1993-11-09
EP0275054B2 (en) 2000-01-26
DE3864149D1 (de) 1991-09-19
AU607959B2 (en) 1991-03-21
ES2029853T3 (es) 1992-10-01
JPH0555483B2 (es) 1993-08-17
EP0275054B1 (en) 1991-08-14
JPS63174924A (ja) 1988-07-19
EP0275054A1 (en) 1988-07-20
ATE66140T1 (de) 1991-08-15

Similar Documents

Publication Publication Date Title
ATE66140T1 (de) Salbengrundlage und salbe.
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
ES2045229T3 (es) Pirrolidinas 1,3-disubstituidas.
GR890100564A (el) Υδατική γέλη με βάση το υαλουρονικό το οξύ και το δεσοξυριβοζονουκλεϊνικό οξύ, χρησιμοποίηση στην κοσμητική και μέ?οδος παρασκευής της.
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
DE3762867D1 (de) Mesomorpher polymerwirkstoff, verwendungsfaehig zur nichtlinearoptik.
ATE135216T1 (de) Verwendung von spiperone-derivate zur immunosuppression
ATE299012T1 (de) Kosmetische zusammensetzung fuer hautregenerierung ohne hautreizung
ES2043609T3 (es) Composiciones de interleucina-2.
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
ATE99669T1 (de) N-2,3-butadienyl-tri-aminoalkanderivate.
ATE148724T1 (de) Carboxyvinylpolymer mit newtonischer viskosität
FI861424A7 (fi) Parannettu menetelmä metallitioneiinin konjugoimiseksi biologisesti aktiivisiin molekyyleihin.
DE58903964D1 (de) Fluessige orale formulierung.
ES2056149T3 (es) Ambliommina, una nueva sustancia activa para la terapia anticoagulante.
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
ATE93731T1 (de) Protein enthaltende waesserige loesungen.
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
DE3677511D1 (de) Oligosaccharide, verfahren zu ihrer herstellung und ihre anwendung.
PT96828A (pt) Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue
ES2063950T3 (es) Una composicion terapeutica utilizada como solucion de irrigacion intraocular.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
DK425886A (da) Oejengelsammensaetning og fremgangsmaade til behandling af oejeninfektioner
DE3685988D1 (de) Verwendung von "naftidrofuryl" zur behandlung von neuropathien.
FR2648458B1 (fr) Acide diallyloxyacetique et ses sels d'addition basiques, leur procede de preparation et leur application comme agent reticulant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 275054

Country of ref document: ES